Literature DB >> 14612426

The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation.

Mei Xiu1, Jiyoung Kim, Ellen Sampson, Chun-Yin Huang, Roger J Davis, K Eric Paulson, Amy S Yee.   

Abstract

The p38 mitogen-activated protein (MAP) kinase signaling pathway participates in both apoptosis and G1 arrest. In contrast to the established role in apoptosis, the documented induction of G1 arrest by activation of the p38 MAP kinase pathway has attracted recent attention with reports of substrates that are linked to cell cycle regulation. Here, we identify the high-mobility group box protein HBP1 transcriptional repressor as a new substrate for p38 MAP kinase. Our previous work had shown that HBP1 inhibits G1 progression in cell and animal models, and thus indicated that HBP1 could be a relevant substrate for p38 MAP kinase in cell cycle regulation. In the present work, a p38 MAP kinase docking site (amino acids [aa] 81 to 125) and a p38 MAP kinase phosphorylation site (serine 401) were identified in the HBP1 protein. Furthermore, the docking and phosphorylation sites on HBP1 were specific for p38 MAP kinase. In defining the role of p38 MAP kinase regulation, the inhibition of p38 MAP kinase activity was shown to decrease HBP1 protein levels by triggering protein instability, as manifested by a decrease in protein half-life. Consistently, a decrease in protein levels was accompanied by a decrease in overall DNA binding activity. A mutation of the p38 MAP kinase phosphorylation site at aa 401 [(S-A)401HBP1] also triggered HBP1 protein instability. While protein stability was compromised by mutation, the specific activities of (S-A)401HBP1 and of wild-type HBP1 appeared comparable for transcriptional repression. This comparison of transcription-specific activity highlighted that p38 MAP kinase regulated HBP1 protein levels but not the intrinsic activity for DNA binding or for transcriptional repression. Finally, p38 MAP kinase-mediated regulation of the HBP1 protein also contributed to the regulation of G1 progression. Together, our work supports a molecular framework in which p38 MAP kinase activity contributes to cell cycle inhibition by increasing HBP1 and other G1 inhibitory factors by regulating protein stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612426      PMCID: PMC262665          DOI: 10.1128/MCB.23.23.8890-8901.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 3.  Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators.

Authors:  P R Yew
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

4.  Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression.

Authors:  C Lemercier; K Duncliffe; I Boibessot; H Zhang; A Verdel; D Angelov; S Khochbin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner.

Authors:  O Casanovas; F Miró; J M Estanyol; E Itarte; N Agell; O Bachs
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

Review 6.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation.

Authors:  J M Kyriakis; J Avruch
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

7.  Regulation of differentiation by HBP1, a target of the retinoblastoma protein.

Authors:  H H Shih; S G Tevosian; A S Yee
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity.

Authors:  K M Lin; W G Zhao; J Bhatnagar; W D Zhao; J P Lu; S Simko; A Schueneman; G E Austin
Journal:  Leukemia       Date:  2001-04       Impact factor: 11.528

9.  HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue.

Authors:  H H Shih; M Xiu; S P Berasi; E M Sampson; A Leiter; K E Paulson; A S Yee
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.

Authors:  E M Sampson; Z K Haque; M C Ku; S G Tevosian; C Albanese; R G Pestell; K E Paulson; A S Yee
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

View more
  21 in total

1.  Phosphorylation of Hsl1 by Hog1 leads to a G2 arrest essential for cell survival at high osmolarity.

Authors:  Josep Clotet; Xavier Escoté; Miquel Angel Adrover; Gilad Yaakov; Eloi Garí; Martí Aldea; Eulàlia de Nadal; Francesc Posas
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

2.  A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis.

Authors:  Shuya Wang; Zhengyi Cao; Junhui Xue; Hui Li; Wei Jiang; Yuning Cheng; Gang Li; Xiaowei Zhang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

3.  The HBP1 transcriptional repressor participates in RAS-induced premature senescence.

Authors:  Xiaowei Zhang; Jiyoung Kim; Robin Ruthazer; Michael A McDevitt; David E Wazer; K Eric Paulson; Amy S Yee
Journal:  Mol Cell Biol       Date:  2006-09-11       Impact factor: 4.272

Review 4.  Cellular senescence and tumor suppressor gene p16.

Authors:  Hani Rayess; Marilene B Wang; Eri S Srivatsan
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

Review 5.  Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence.

Authors:  Yingxi Xu; Na Li; Rong Xiang; Peiqing Sun
Journal:  Trends Biochem Sci       Date:  2014-05-09       Impact factor: 13.807

6.  HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence.

Authors:  Kewu Pan; Yifan Chen; Mendel Roth; Weibin Wang; Shuya Wang; Amy S Yee; Xiaowei Zhang
Journal:  Mol Cell Biol       Date:  2012-12-17       Impact factor: 4.272

Review 7.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 8.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

9.  HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase.

Authors:  Stephen P Berasi; Mei Xiu; Amy S Yee; K Eric Paulson
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms.

Authors:  Ye Su; Xin Cheng; Yaohong Tan; Yunhui Hu; Yuan Zhou; Juanni Liu; Yuanfu Xu; Yinliang Xie; Caiyun Wang; Yingdai Gao; Jianxiang Wang; Tao Cheng; Chunzheng Yang; Dongsheng Xiong; Hua Miao
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.